The Canadian Agency for Drugs and Technologies in Health (CADTH) published an interesting new report on January 29, 2021 about Health Technology Trends to Watch. The report identifies the following list of emerging trends...more
3/30/2021
/ 3D Printing ,
Artificial Intelligence ,
Augmented Reality ,
CADTH ,
Canada ,
Connected Items ,
Coronavirus/COVID-19 ,
Diagnostic Tests ,
Health Canada ,
Health Technology ,
Life Sciences ,
Medical Devices ,
Pain Management ,
Pharmaceutical Industry ,
Popular ,
Regenerative Medicine ,
Telehealth ,
Virtual Reality ,
Virus Testing
In This Issue:
Ontario Court of Appeal allows Sanofi and Schering to plead that Federal Court ramipril patent invalidity decision was flawed due to “promise doctrine” -
In an action by Apotex for compensation from...more
12/6/2018
/ Apotex ,
Appeals ,
Biosimilars ,
CADTH ,
Canada ,
Eli Lilly ,
Lack of Novelty ,
Leave to Appeal ,
Life Sciences ,
Motion To Strike ,
Patent Invalidity ,
Patented Medicine Prices Review Board (PMPRB) ,
Patents ,
Pharmaceutical Patents ,
PMNOC Regulations ,
Promise Doctrine ,
Proposed Amendments ,
Remedies ,
Sandoz ,
Supreme Court of Canada ,
Teva Pharmaceuticals
In October 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) issued an interesting Environmental Scan on International Policies on the Appropriate Use of Biosimilar Drugs (Report). This Report outlines...more
11/30/2018
/ Biosimilars ,
CADTH ,
Canada ,
Drug Pricing ,
Global Market ,
Incentives ,
International Regulatory Standards ,
Pharmacies ,
Policies and Procedures ,
Prescribing Authority ,
Prescription Drugs